{{Rsnum
|rsid=498186
|Gene=COX6CP3
|Chromosome=11
|position=102798914
|Orientation=plus
|GMAF=0.4408
|Gene_s=COX6CP3,MMP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 27.0 | 53.2 | 19.8
| HCB | 26.5 | 45.6 | 27.9
| JPT | 22.1 | 54.0 | 23.9
| YRI | 59.6 | 35.6 | 4.8
| ASW | 43.9 | 49.1 | 7.0
| CHB | 26.5 | 45.6 | 27.9
| CHD | 35.2 | 46.3 | 18.5
| GIH | 36.6 | 51.5 | 11.9
| LWK | 50.9 | 40.0 | 9.1
| MEX | 28.6 | 41.1 | 30.4
| MKK | 46.2 | 36.5 | 17.3
| TSI | 27.5 | 52.9 | 19.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23077567
|Title=Assessment of the association of matrix metalloproteinases with myopia, refractive error and ocular biometric measures in an Australian cohort
|OA=1
}}

{{PMID Auto
|PMID=19318431
|Title=No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.
|OA=1
}}

{{PMID Auto
|PMID=19435861
|Title=No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=20078883
|Title=Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.
|OA=1
}}

{{PMID Auto
|PMID=22198560
|Title=Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}